Page last updated: 2024-09-05

sb 203580 and ropivacaine

sb 203580 has been researched along with ropivacaine in 2 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(ropivacaine)
Trials
(ropivacaine)
Recent Studies (post-2010) (ropivacaine)
3,48941,1373,8691,9821,857

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Colvin, HP; Gerner, P; Haller, I; Klimaschewski, L; Lang, L; Lirk, P; Tomaselli, B1
Chen, Y; Song, Z; Sun, Z; Wang, E; Ye, Z; Zhang, Z1

Other Studies

2 other study(ies) available for sb 203580 and ropivacaine

ArticleYear
In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity.
    Anesthesia and analgesia, 2008, Volume: 106, Issue:5

    Topics: Amides; Anesthetics, Local; Animals; Anthracenes; Bupivacaine; Butadienes; Cell Size; Cell Survival; Cells, Cultured; Cytoprotection; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Ganglia, Spinal; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lidocaine; Membrane Potentials; Mitogen-Activated Protein Kinases; Neurons, Afferent; Nitriles; p38 Mitogen-Activated Protein Kinases; Phenotype; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Ropivacaine; Sodium Channels

2008
[P38 MAPK inhibitor SB203580 attenuates the toxicity of ropivacaine on PC12 cells].
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2019, Sep-28, Volume: 44, Issue:9

    Topics: Anesthetics, Local; Animals; Apoptosis; Imidazoles; p38 Mitogen-Activated Protein Kinases; PC12 Cells; Pyridines; Rats; Ropivacaine

2019